Back to search

Article

Acute Phase Reactions in Osteoporotic Patients receiving Intravenous Zoledronic Acid: A Multi-Centre Retrospective Cohort Study

2025-06-20

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Intravenous Zoledronic Acid (IV ZA) is a third-generation bisphosphonates used for osteoporosis with once-yearly administration demonstrating benefits in improvement of bone mineral density and fracture risk reduction. However, acute phase reactions (APRs) pose challenges, often leading to treatment discontinuation. This study aims to assess APR incidence in oste...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c5308139-02b5-5bce-859b-cd016dfb4ec5
DOI
10.21203/rs.3.rs-6650236/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Acute Phase Reactions in Osteoporotic Patients receiving Intravenous Zoledronic Acid: A Multi-Centre Retrospective Cohort StudyDOI 10.21203/rs.3.rs-6650236/v1
Adverse event analysis and signal detection of calcitonin gene-related peptide inhibitors using the FDA Adverse Event Reporting System databaseSemantic proximity
Common Causes and Characteristics of Adverse Drug Reactions in Older Adults: A Retrospective StudySemantic proximity
Proton-Pump Inhibitors Versus H2-Receptor Antagonists on the Risk of Major Osteoporotic Fractures: A Global Propensity-Score-Matched Cohort StudySemantic proximity
Simplifying the dental/periodontal management of patients with metabolic bone fragility receiving treatment with denosumabSemantic proximity
The risk of anti-osteoporotic agent-induced severe cutaneous adverse drug reactions and their association with HLA.Semantic proximity
Pharmacovigilance analysis of inclisiran:a real-world assessment based on the FAERS databaseSemantic proximity
Reduction of pain and functional disability over time in patients treated with zavegepant: A Post-hoc analysis of the BHV3500-301 Phase 3 Randomized Controlled TrialSemantic proximity
Effectiveness and Safety of Intravenous Golimumab With and Without Concomitant Methotrexate in Patients With Rheumatoid Arthritis in the Prospective, Noninterventional AWARE StudySemantic proximity
Prevalence of late stage in 507 Medication-related osteonecrosis of the jaws (MRONJ) sites: comparison between cancer and osteometabolic patientsSemantic proximity
Renal Outcomes and Dosage Considerations Associated with Bisphosphonate Use: A Systematic Review of Randomized Clinical TrialsSemantic proximity
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for OsimertinibSemantic proximity
Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss Clinical Quality Management cohortSemantic proximity
Select a neighboring publication to make it the new centre.